BioSpace News Archive

Business

Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Updates

Third fiscal quarter 2021 total revenues of $54.4 million, including net product revenue of $29.3 million Net product revenue from U.S. sales of ORGOVYX ® of $24.4 million.

January 26, 2022
·
20 min read
Business

Sharps Compliance Reports Fiscal 2022 Second Quarter Results

Second quarter revenue of $18.9 million increased 11% from the prior year and 36% sequentially.

January 26, 2022
·
18 min read
Lone Star Bio

Distalmotion Raises $90M to Accelerate Adoption of Surgical Robot Dexter

Distalmotion announced today the closing of a USD 90 million Series E financing to support the global commercialization of its surgical robot Dexter.

January 26, 2022
·
3 min read
Drug Development

Medicenna Announces Peer-Reviewed Publication of Preclinical Data on MDNA11 in the Journal for ImmunoTherapy of Cancer

Medicenna Therapeutics Corp. today announced the peer-reviewed publication of preclinical data on MDNA11.

January 26, 2022
·
8 min read
Business

IONETIX and PRECISION MOLECULAR Inc. Announce Supply Agreement for Astatine-211

Agreement secures commerical supply of Astatine-211 to support the clinical development of PMI’s targeted alpha therapies.

January 26, 2022
·
3 min read
Drug Development

BioTheryX Doses First Patient in Phase 1 Study Investigating Lead Protein Degrader Candidate BTX-1188

BioTheryX, Inc. today announced dosing of the first-in human Phase 1 study investigating its lead candidate BTX-1188.

January 26, 2022
·
3 min read
Business

Mednow Awarded 2022 Best Workplace™ - Start-ups

Mednow Awarded 2022 Best Workplace.

January 26, 2022
·
5 min read
Business

Flatiron Health Announces RWD Partnership With Japan’s NCCHE

Flatiron Health Ⓡ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers.

January 26, 2022
·
3 min read
BiondVax to Present at Edison Group’s Open House Conference

BiondVax Pharmaceuticals Ltd. announced that it is presenting at the Edison Open House: Global Healthcare 2022 conference.

January 26, 2022
·
3 min read
Business

Enzyvant Appoints Johanna Rossell as Chief Commercial OfficerIndustry veteran brings extensive experience including tissue-based and regenerative therapies

Enzyvant today announced the appointment of Johanna Rossell as Chief Commercial Officer.

January 26, 2022
·
7 min read